NCT05807503View on ClinicalTrials.gov

Evaluation of the Effect of Neuroprotective Drug on Treatment Result in Patients After Traumatic Brain Injury

CompletedOBSERVATIONAL
Enrollment

56

Participants

Timeline

Start Date

February 1, 2020

Primary Completion Date

October 31, 2022

Study Completion Date

November 30, 2022

Conditions
TBI (Traumatic Brain Injury)
Interventions
DRUG

Cerebrolysin

Cerebrolysin administration in short period of time after TBI

Trial Locations (1)

70-204

Pomeranian Medical University, Szczecin

All Listed Sponsors
lead

Pomeranian Medical University Szczecin

OTHER

NCT05807503 - Evaluation of the Effect of Neuroprotective Drug on Treatment Result in Patients After Traumatic Brain Injury | Biotech Hunter | Biotech Hunter